{{Infobox drug
| drug_name         =
| INN               =
| type              =<!-- empty -->
| IUPAC_name        = 
| image             = Ethambutol.svg
| width             = 
| alt               = 
| image2            = Ethambutol substance photo.jpg
| width2            = 
| alt2              = 
| imageL            =
| widthL            =
| altL              = 
| imageR            = 
| widthR            = 
| altR              = 
| caption           =  Stereo, skeletal formula of ethambutol

<!-- Clinical data -->
| synonyms          = (2''S'',2’''S'')-2,2’-(Ethane-1,2-diyldiimino)dibutan-1-ol<ref>{{cite web|title=ethambutol (CHEBI:4877)|url=https://www.ebi.ac.uk/chebi/searchId.do?chebiId=4877|work=Chemical Entities of Biological Interest|publisher=European Bioinformatics Institute|accessdate=26 April 2012|location=UK|date=18 August 2010|at=Main|deadurl=no|archiveurl=https://web.archive.org/web/20140719040040/http://www.ebi.ac.uk/chebi/searchId.do?chebiId=4877|archivedate=19 July 2014|df=}}</ref>
| pronounce         =
| tradename         = Myambutol, Etibi,<ref name=Ric2015/> Servambutol, others
| Drugs.com         = {{drugs.com|monograph|ethambutol-hydrochloride}}
| MedlinePlus       = 
| licence_EU        = <!-- EMA requires brand name -->
| licence_US        = <!-- FDA may use generic name -->
| DailyMedID        = <!-- preference to licence_US -->
| pregnancy_AU      = <!-- A/B1/B2/B3/C/D/X -->
| pregnancy_AU_comment =      
| pregnancy_US      =  C
| pregnancy_US_comment =<ref name=AHFS2016/> 
| pregnancy_category= 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = by mouth
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU_comment = 
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA_comment = 
| legal_DE = <!-- Anlage I, II, III or Unscheduled-->
| legal_DE_comment = 
| legal_NZ = <!-- Class A, B, C -->
| legal_NZ_comment = 
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C -->
| legal_UK_comment = 
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_US_comment = 
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_UN_comment = 
| legal_status      = <!--For countries not listed above-->
<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 20–30%
| metabolism        = liver
| metabolites       =
| onset             = 
| elimination_half-life = 3–4 hours
| duration_of_action =
| excretion         =
<!-- Identifiers -->
| CAS_number        = 74-55-5
| CAS_supplemental  =  {{cascite|correct|??}}
| ATCvet            = 
| ATC_prefix        = J04
| ATC_suffix        = AK02
| ATC_supplemental  = 
| PubChem           = 14052
| PubChemSubstance  = 
| IUPHAR_ligand     = 
| DrugBank          = DB00330
| ChemSpiderID      = 13433
| UNII              = 8G167061QZ
| KEGG              = D07925
| ChEBI             = 4877
| ChEMBL            = 44884
| NIAID_ChemDB      =
<!-- Chemical data -->
| chemical_formula  = <!-- C=10 | H=24 | N=2 | O=2 -->
| molecular_weight  = 
| SMILES            = CC[C@@H](CO)NCCN[C@@H](CC)CO
| Jmol              = 
| StdInChI          = 1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3/t9-,10-/m0/s1
| StdInChI_comment  = {{stdinchicite|correct|chemspider}}
| StdInChIKey       = AEUTYOVWOVBAKS-UWVGGRQHSA-N
| density           = 
| density_notes     = 
| melting_point     = 
| melting_high      = 
| melting_notes     = 
| boiling_point     = 
| boiling_notes     = 
| solubility        = 
| specific_rotation = 
}}
<!-- Definition and medical uses -->
'''Ethambutol''' ('''EMB''', '''E''') is a medication primarily used to treat [[tuberculosis]].<ref name=AHFS2016/> It is usually given in combination with other [[Tuberculosis treatment|tuberculosis medications]], such as [[isoniazid]], [[rifampicin]] and [[pyrazinamide]].<ref name=WHO2008>{{cite book|title=WHO Model Formulary 2008|date=2009|publisher=World Health Organization|isbn=9789241547659|pages=136, 138, 588, 603|url=http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161213060118/http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|archivedate=13 December 2016|df=}}</ref> It may also be used to treat ''[[Mycobacterium avium complex]]'', and ''[[Mycobacterium kansasii]]''.<ref name=AHFS2016/> It is taken by mouth.<ref name=AHFS2016>{{cite web | title = Ethambutol Hydrochloride | url = http://www.drugs.com/monograph/ethambutol-hydrochloride.html | work = The American Society of Health-System Pharmacists | accessdate = 10 December 2016 | deadurl = no | archiveurl = https://web.archive.org/web/20160605151353/http://www.drugs.com/monograph/ethambutol-hydrochloride.html | archivedate = 5 June 2016 | df =  }}</ref>

<!-- Adverse effects -->
Common side effects include problems with vision, joint pain, nausea, headaches, and feeling tired.<ref name=AHFS2016/> Other side effects include [[liver problems]] and [[allergic reactions]].<ref name=AHFS2016/> It is not recommended in people with [[optic neuritis]], significant [[kidney problems]], or under the age of five.<ref name=WHO2008/> Use during [[pregnancy]] or [[breastfeeding]] has not been found to cause harm.<ref name=WHO2008/><ref>{{cite web|title=Prescribing medicines in pregnancy database|url=http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|work=Australian Government|accessdate=22 April 2014|date=3 March 2014|deadurl=no|archiveurl=https://web.archive.org/web/20140408040902/http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|archivedate=8 April 2014|df=}}</ref> In the United States the FDA has raised concerns about eye issues in the baby if used during pregnancy.<ref name=AHFS2016/> Ethambutol is believed to work by interfering with the bacteria's [[cellular metabolism|metabolism]].<ref name=AHFS2016/>

<!-- Society and culture -->
Ethambutol was discovered in 1961.<ref>{{cite book|last1=Landau|first1=Ralph|last2=Achilladelis|first2=Basil|last3=Scriabine|first3=Alexander|title=Pharmaceutical Innovation: Revolutionizing Human Health|date=1999|publisher=Chemical Heritage Foundation|isbn=9780941901215|page=171|url=https://books.google.ca/books?id=IH4lPs6S1bMC&pg=PA171|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20161220090026/https://books.google.ca/books?id=IH4lPs6S1bMC&pg=PA171|archivedate=2016-12-20|df=}}</ref> It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> Ethambutol is available as a [[generic medication]].<ref name=Ric2015/> The wholesale cost in the [[developing world]] is about 2.58 to 4.73 USD per month.<ref name=ERC2014>{{cite web|title=Ethambutol|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=ETH400T&s_year=2014&year=2014&str=400%20mg&desc=Ethambutol&pack=new&frm=TAB-CAP&rte=PO&class_code2=06%2E2%2E4%2E&supplement=&class_name=%2806%2E2%2E4%2E%29Antituberculosis%20medicines%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=8 December 2016}}</ref> In the United States it costs 100 to 200 USD per month.<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=48}}</ref>

==Medical uses==
Ethambutol is used along with other medications to treat a number of infections including: [[tuberculosis]], ''[[Mycobacterium avium complex]]'', and ''[[Mycobacterium kansasii]]''.<ref name=AHFS2016/>

==Adverse effects==
{{refimprove section|date=May 2014}}
* [[Optic neuritis]]<ref name="pmid16710500">{{cite journal |author=Lim SA |title=Ethambutol-associated optic neuropathy |journal=Ann. Acad. Med. Singap. |volume=35 |issue=4 |pages=274–8 |date=April 2006 |pmid=16710500 |doi= |url=http://www.annals.edu.sg/pdf/35VolNo4200605/V35N4p274.pdf |deadurl=no |archiveurl=https://web.archive.org/web/20090816060133/http://www.annals.edu.sg/pdf/35VolNo4200605/V35N4p274.pdf |archivedate=2009-08-16 |df= }}</ref> (hence contraindicated in children below six years of age)
* [[Red-green color blindness]]<ref>{{cite book|last1=Tripathi|first1=K D|title=Essentials of MEDICAL PHARMACOLOGY|date=August 2015|publisher=JAYPEE BROTHERS MEDICAL PUBLISHERS|location=India|isbn=978-93-5025-937-5|page=769|edition=Seventh}}</ref>
* [[Peripheral neuropathy]]
* [[Arthralgia]]
* Hyperuricaemia
* Vertical [[pathologic nystagmus|nystagmus]]
* Milk skin reaction

==Mechanism of action==
Ethambutol is [[bacteriostatic]] against actively growing TB bacilli. It works by obstructing the formation of [[cell wall]]. [[Mycolic acid]]s attach to the 5'-hydroxyl groups of [[arabinose|<small>D</small>-arabinose]] residues of [[arabinogalactan]] and form mycolyl-arabinogalactan-peptidoglycan complex in the cell wall. It disrupts arabinogalactan synthesis by inhibiting the enzyme [[arabinosyl transferase]]. Disruption of the arabinogalactan synthesis inhibits the formation of this complex and leads to increased permeability of the cell wall.

==Pharmacokinetics==
It is well absorbed from the [[gastrointestinal tract]] and well distributed in body tissues and fluids.  50% is excreted unchanged in urine.

==References==
{{reflist|32em}}

==External links==
*[https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682550.html Medline Plus drug information]

{{antimycobacterials}}

[[Category:Antibiotics]]
[[Category:Anti-tuberculosis drugs]]
[[Category:World Health Organization essential medicines]]
[[Category:Diols]]
[[Category:RTT]]